MacroGenics Surpasses Analyst Target Price of $3.40/Share

MacroGenics, Inc. shares have crossed above the average analyst 12-month target price of $3.40, trading at $3.43/share. Analysts have set 5 different target prices, ranging from $2.00 to $5.00, with an average of $3.40. This signals investors to reassess the company and decide if the valuation has gotten stretched or if it's time to take profits.